Search research articles
Contact Us
Filters
Showing results (241-250 of 288) with videos related to
Page
of 29
Sort By:
Biochemical and Biophysical Research Communications
|
November 24, 2004
Targeted disruption of mouse ortholog of the human MYH9 responsible for macrothrombocytopenia with different organ involvement: hematological, nephrological, and otological studies of heterozygous KO mice
Tadashi Matsushita, Hideo Hayashi, Shinji Kunishima, et al.
Blood
|
February 7, 2012
Retrospective analysis of prognostic factors for angioimmunoblastic T-cell lymphoma: a multicenter cooperative study in Japan
Takashi Tokunaga, Kazuyuki Shimada, Kazuhito Yamamoto, et al.
International Journal of Hematology
|
April 11, 2009
Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia: final results of Japanese multicenter cooperative study
Yukio Kobayashi, Kensei Tobinai, Akihiro Takeshita, et al.
Cancer
|
June 27, 2013
The demarcation between younger and older acute myeloid leukemia patients: a pooled analysis of 3 prospective studies
Masamitsu Yanada, Shigeki Ohtake, Shuichi Miyawaki, et al.
International Journal of Hematology
|
June 26, 2010
Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia: results of a prospective study in Japan
Tadashi Nagai, Jin Takeuchi, Nobuaki Dobashi, et al.
Cancer Biomarkers : Section a of Disease Markers
|
April 11, 2016
Prognostic significance of Wilms tumor 1 mRNA expression levels in peripheral blood and bone marrow in patients with myelodysplastic syndromes
Sumiko Kobayashi, Yasunori Ueda, Yasuhito Nannya, et al.
Cancer Science
|
July 11, 2013
Role of hematopoietic stem cell transplantation for relapsed acute promyelocytic leukemia: a retrospective analysis of JALSG-APL97
Hiroyuki Fujita, Norio Asou, Masako Iwanaga, et al.
Blood
|
December 1, 2017
A novel irreversible FLT3 inhibitor, FF-10101, shows excellent efficacy against AML cells with <i>FLT3</i> mutations
Takeshi Yamaura, Toshiyuki Nakatani, Ken Uda, et al.
Annals of Hematology
|
December 3, 2017
Underweight status at diagnosis is associated with poorer outcomes in adult patients with acute myeloid leukemia: a retrospective study of JALSG AML 201
Kaito Harada, Noriko Doki, Takeshi Hagino, et al.
Annals of Hematology
|
April 26, 2018
Final analysis of the JALSG Ph+ALL202 study: tyrosine kinase inhibitor-combined chemotherapy for Ph+ALL
Yoshihiro Hatta, Shuichi Mizuta, Keitaro Matsuo, et al.
Page
of 29
Search research articles
Search
Showing results (241-250 of 288) with videos related to
Sort By:
Page
of 29
Biochemical and Biophysical Research Communications
|
November 24, 2004
Targeted disruption of mouse ortholog of the human MYH9 responsible for macrothrombocytopenia with different organ involvement: hematological, nephrological, and otological studies of heterozygous KO mice
Tadashi Matsushita, Hideo Hayashi, Shinji Kunishima, et al.
Blood
|
February 7, 2012
Retrospective analysis of prognostic factors for angioimmunoblastic T-cell lymphoma: a multicenter cooperative study in Japan
Takashi Tokunaga, Kazuyuki Shimada, Kazuhito Yamamoto, et al.
International Journal of Hematology
|
April 11, 2009
Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia: final results of Japanese multicenter cooperative study
Yukio Kobayashi, Kensei Tobinai, Akihiro Takeshita, et al.
Cancer
|
June 27, 2013
The demarcation between younger and older acute myeloid leukemia patients: a pooled analysis of 3 prospective studies
Masamitsu Yanada, Shigeki Ohtake, Shuichi Miyawaki, et al.
International Journal of Hematology
|
June 26, 2010
Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia: results of a prospective study in Japan
Tadashi Nagai, Jin Takeuchi, Nobuaki Dobashi, et al.
Cancer Biomarkers : Section a of Disease Markers
|
April 11, 2016
Prognostic significance of Wilms tumor 1 mRNA expression levels in peripheral blood and bone marrow in patients with myelodysplastic syndromes
Sumiko Kobayashi, Yasunori Ueda, Yasuhito Nannya, et al.
Cancer Science
|
July 11, 2013
Role of hematopoietic stem cell transplantation for relapsed acute promyelocytic leukemia: a retrospective analysis of JALSG-APL97
Hiroyuki Fujita, Norio Asou, Masako Iwanaga, et al.
Blood
|
December 1, 2017
A novel irreversible FLT3 inhibitor, FF-10101, shows excellent efficacy against AML cells with <i>FLT3</i> mutations
Takeshi Yamaura, Toshiyuki Nakatani, Ken Uda, et al.
Annals of Hematology
|
December 3, 2017
Underweight status at diagnosis is associated with poorer outcomes in adult patients with acute myeloid leukemia: a retrospective study of JALSG AML 201
Kaito Harada, Noriko Doki, Takeshi Hagino, et al.
Annals of Hematology
|
April 26, 2018
Final analysis of the JALSG Ph+ALL202 study: tyrosine kinase inhibitor-combined chemotherapy for Ph+ALL
Yoshihiro Hatta, Shuichi Mizuta, Keitaro Matsuo, et al.
Page
of 29